Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Coltom
    Junior Member
    • Dec 2012
    • 5

    #1

    Help/advise to NGS virgin....

    Dear All

    I haven't previously had any reason to apply NGS in my research but do now and am finding I've been left behind a bit! So - and I am reading all I can including posts here - please be kind! I am writing a grant application that was designed, initially, to use just 16S rRNA phylogenetic profiling to compare species abundances in gut microbiota between patients in a group with a specific metabolic disorder and matched controls. It was subsequently suggested that some form of metabolic network analyses might be usefully applied and that this would preferably require shotgun metagenomic data be obtained in addition to the 16S.

    Would applying both these approaches be justified in that they would/should provide different but complementary data sets?

    I am interested in a specific metabolic pathway mediated by the gut microbiota and would like to determine whether this pathway is over/under represented in the microbiota between the two groups. Should we concentrate on reassembling just this KEGG-annotated pathway from the shotgun metagenomic data or is there a more global metabolic network analysis scheme that could be applied that would not only reveal any differences in this specific pathway but would, in addition, provide insight into any other differences in the metabolic capacity of the gut microbiota between test and control groups?

    Lastly, there appear to be a plethora of different software methods to clean, filter, QC the original sequence data before its considered fit to use. Is there any sort of a 'flow-chart' that would guide a beginner through these options?
  • awiser
    Junior Member
    • May 2013
    • 1

    #2
    Look into the program Humann: http://huttenhower.sph.harvard.edu/humann

    It should be a good starting point for metabolic pathway profiling of a metagenome sample.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    19 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...